早发性自然绝经与手术绝经与心血管疾病发病风险的关联
该队列研究基于英国生物银行144260名40至69岁绝经后女性,随访中位7年。早发性自然绝经(<40岁)和手术绝经(<40岁双侧卵巢切除)与心血管疾病复合终点风险分别增加36%和87%,且风险因素调整后仍显著,但绝对风险增幅较小。
要点
- 早发性自然绝经(<40岁)心血管疾病复合终点风险比为1.36(95%CI 1.19-1.56)。
- 早发性手术绝经(<40岁双侧卵巢切除)心血管疾病复合终点风险比为1.87(95%CI 1.36-2.58)。
- 早发性手术绝经的绝对风险增加5.57/1000人年,高于自然绝经的3.08/1000人年。
核心结论
- 早发性自然绝经和手术绝经(<40岁)与绝经后女性心血管疾病复合终点风险小幅但统计学显著的增加相关。
- 需要进一步研究以理解这些关联的潜在机制。
研究设计与样本
- 队列研究(英国生物银行),招募2006至2010年英国成年居民。
- 纳入144260名40至69岁且入组时已绝经的女性,随访至2016年8月。
主要发现
- 主要复合终点包括冠状动脉疾病、心力衰竭、主动脉瓣狭窄、二尖瓣反流、心房颤动、缺血性卒中、外周动脉疾病和静脉血栓栓塞。
- 无早发性绝经组主要终点发生率5.70/1000人年(5415例,3.9%);自然早发性绝经组8.78/1000人年(292例,6.0%),较无早发性绝经组差值+3.08/1000人年(95%CI 2.06-4.10;P<.001);手术早发性绝经组11.27/1000人年(49例,7.6%),差值+5.57/1000人年(95%CI 2.41-8.73;P<.001)。
- 调整常规心血管疾病危险因素和绝经激素治疗后,自然早发性绝经主要终点风险比HR 1.36(95%CI 1.19-1.56;P<.001),手术早发性绝经HR 1.87(95%CI 1.36-2.58;P<.001)。
临床怎么用
- 近期指南支持使用40岁前绝经史来细化中年女性动脉粥样硬化性心血管疾病风险评估。
- 该人群心血管疾病风险的稳健数据尚缺乏。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Recent guidelines endorse using history of menopause before age 40 years to refine atherosclerotic cardiovascular disease risk assessments among middle-aged women. Robust data on cardiovascular disease risk in this population are lacking. OBJECTIVE: To examine the development of cardiovascular diseases and cardiovascular risk factors in women with natural and surgical menopause before age 40 years. DESIGN, SETTING, AND PARTICIPANTS: Cohort study (UK Biobank), with adult residents of the United Kingdom recruited between 2006 and 2010. Of women who were 40 to 69 years old and postmenopausal at study enrollment, 144 260 were eligible for inclusion. Follow-up occurred through August 2016. EXPOSURES: Natural premature menopause (menopause before age 40 without oophorectomy) and surgical premature menopause (bilateral oophorectomy before age 40). Postmenopausal women without premature menopause served as the reference group. MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of incident coronary artery disease, heart failure, aortic stenosis, mitral regurgitation, atrial fibrillation, ischemic stroke, peripheral artery disease, and venous thromboembolism. Secondary outcomes included individual components of the primary outcome, incident hypertension, hyperlipidemia, and type 2 diabetes. RESULTS: Of 144 260 postmenopausal women included (mean [SD] age at enrollment, 59.9 [5.4] years), 4904 (3.4%) had natural premature menopause and 644 (0.4%) had surgical premature menopause. Participants were followed up for a median of 7 years (interquartile range, 6.3-7.7). The primary outcome occurred in 5415 women (3.9%) with no premature menopause (incidence, 5.70/1000 woman-years), 292 women (6.0%) with natural premature menopause (incidence, 8.78/1000 woman-years) (difference vs no premature menopause, +3.08/1000 woman-years [95% CI, 2.06-4.10]; P < .001), and 49 women (7.6%) with surgical premature menopause (incidence, 11.27/1000 woman-years) (difference vs no premature menopause, +5.57/1000 woman-years [95% CI, 2.41-8.73]; P < .001). For the primary outcome, natural and surgical premature menopause were associated with hazard ratios of 1.36 (95% CI, 1.19-1.56; P < .001) and 1.87 (95% CI, 1.36-2.58; P < .001), respectively, after adjustment for conventional cardiovascular disease risk factors and use of menopausal hormone therapy. CONCLUSIONS AND RELEVANCE: Natural and surgical premature menopause (before age 40 years) were associated with a small but statistically significant increased risk for a composite of cardiovascular diseases among postmenopausal women. Further research is needed to understand the mechanisms underlying these associations.
引用
- Honigberg MC, Zekavat SM, Aragam K, et al. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. JAMA. 2019. PMID: 31738818. doi:10.1001/jama.2019.19191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。